沃华医药(002107.SZ)发布2025年度业绩，归母净利润9571.53万元，增长162.93%

Core Viewpoint - Wohua Pharmaceutical (002107.SZ) reported a revenue of 817 million yuan for the year 2025, reflecting a year-on-year growth of 6.96% [1] - The net profit attributable to shareholders reached 95.71 million yuan, marking a significant increase of 162.93% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 92.11 million yuan, up by 168.20% year-on-year [1] - The basic earnings per share stood at 0.17 yuan [1] - The company proposed a cash dividend of 1.46 yuan (including tax) for every 10 shares to all shareholders [1]